Revolutionary lung imaging technology, vibration response imaging (VRI),
available in EU
20 September 2005
Brussels, Belgium & Or-Akiva, Israel. A new technology for imaging lungs,
vibration response imaging, has been approved for use in the EU. Vibration
Response Imaging (VRI) provides a dynamic image of the lungs, delivering
both structural and functional information to aid in assessing lung
condition.
Deep Breeze Ltd., manufacturer of the VRI(XP)(TM) system, announced that
it has received a CE mark, declaring the system "safe and effective" and
allowing the company to market the technology to physicians in European
Union countries.
"The VRI(XP) system adds a new dimension to interventional pulmonology
and evaluation of patients with lung transplants," said Professor Mordechai
R. Kramer of Petah-Tikva, Israel. "We will be able to assess lung function
much more effectively and non-invasively". Professor Kramer is performing
clinical trials at the Pulmonary Institute, Rabin Medical Center affiliated
to Sackler School of Medicine, Tel-Aviv University.
The VRI(XP)(TM) system received the CE mark after an audit, which found
the device safe and effective to use, and approved it as a lung diagnostic
device.
"We are introducing a new imaging technology for the human body, which is
radiation-free and organ oriented. Unlike MRI (magnetic resonance imaging),
X-ray or Ultrasound, VRI utilizes passive vibration energy that is naturally
created in organs to produce a dynamic image of the organ. The development
of the first VRI for the lungs was based on the finding that the lung
vibration energy directly correlates to the lung airflow. Vibration Response
Imaging displays for the first time a dynamic image of the lungs as they
function," said Igal Kushnir, MD, CEO and founder of Deep Breeze Ltd. that
is based in Or-Akiva, Israel. "The VRI(XP) images expand the physician's
understanding of the condition of the lungs hence improving patient
management and outcome".
The system is currently being used at sites in Europe, the USA and
Israel. The VRI(XP)(TM) system will be on display for the first time in
Europe at the European Respiratory Society meeting in Copenhagen, Denmark,
September 17-21, 2005.
First deliveries of the VRI(XP) are expected in the fourth quarter of
2005.
To top |
|